Itamar Medical to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019

CAESAREA, Israel, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic medical devices for sleep apnea and uses a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the cardiology market, announced today that Gilad Glick, President and Chief Executive Officer of Itamar Medical, will participate in a fireside chat at the Piper Jaffray 31st Annual Healthcare Conference in New York, NY, on Wednesday, December 4, 2019 at 4:30 PM ET.

A live and archived webcast of the presentation will be available on the investor section of the Company’s website at: .

For more information about the conference, or to schedule a one-on-one meeting with Itamar Medical’s management, please contact your Piper Jaffray representative.

About Itamar Medical Ltd.

Itamar Medical is engaged in research, development, sales and marketing of non-invasive medical devices for the diagnosis of respiratory sleep disorders and uses a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the cardiology market. The Company offers a Total Sleep Solution to help physicians provide comprehensive sleep apnea management in a variety of clinical environments to optimize patient care and reduce healthcare costs. Its flagship PAT®-based product, the WatchPAT™ device, is a home-use diagnostic device for sleep breathing disorders. Its digital health platform, including CloudPAT™ and SleePATH™, facilitates seamless and complete care pathway management in a complex environment. It also offers the EndoPAT™ system, an FDA-cleared device to test endothelial dysfunction and to evaluate the risk of heart disease and other cardiovascular diseases. Itamar Medical is a public company traded on the Nasdaq and on the Tel Aviv Stock Exchanges, and is based in Caesarea, Israel with U.S. headquarters based in Atlanta, GA. For additional information visit .

Contact:

David Carey

Lazar FINN Partners



212-867-1762

Eran Gabbai, Partner

Galbert-Kahana Investor Relations and Public Relations

Tel:

* The contents of any website or hyperlinks mentioned in this press release are for informational purposes and the contents thereof are not part of this press release